Biogen Idec/Elan Report Positive Two-Year Tysabri Follow-On Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Partners also announce that no new reports of progressive multifocal leukoencephalopathy have been associated with the multiple sclerosis therapy - at the international MS meeting in Prague.